Tandem Diabetes Care
TNDM
TNDM
226 hedge funds and large institutions have $1.45B invested in Tandem Diabetes Care in 2023 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 80 increasing their positions, 89 reducing their positions, and 44 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
12% less capital invested
Capital invested by funds: $1.65B → $1.45B (-$204M)
41% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 44
Holders
226
Holding in Top 10
–
Calls
$7.01M
Puts
$7.98M
Top Buyers
| 1 | +$49.3M | |
| 2 | +$33.9M | |
| 3 | +$17.5M | |
| 4 |
Jennison Associates
New York
|
+$16.7M |
| 5 |
CC
Chicago Capital
Chicago,
Illinois
|
+$16.4M |
Top Sellers
| 1 | -$32.6M | |
| 2 | -$11.7M | |
| 3 | -$11.3M | |
| 4 |
BNP Paribas Asset Management
Paris,
France
|
-$10.5M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$9.93M |